RIP antibody | knockout validation | Cell Signaling 3493

This is a knockout-validated antibody summary, based on publications "Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation" [1] (western blot, see figure 3f in the article), "RIPK1 protects from TNF-α-mediated liver damage during hepatitis", as discussed below [2]. The antibody was also validated for Western blot in another article "PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP" (figure 3c) [3]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

RIP antibody | knockout validation | Cell Signaling 3493 figure 1
Figure 1. (a) Western blot analysis of RIPK1 and β-tubulin in protein extracts issued from the livers of WT and Ripk1LPC-KO mice. (b) Pictures of liver tissue sections analyzed by IHC for RIPK1 issued from WT and Ripk1LPC-KO mice challenged with PBS. From [2].
Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: RIP

Catalog number: 3493

Summary: Rabbit monoclonal IgG against a synthetic peptide corresponding to residues surrounding Leu190 of human RIP. Reacts with Human, Mouse, Rat, Hamster, Monkey. Suitable for western blot, immunoprecipitation, immunofluorescence/immunocytochemistry, and flow cytometry.

Validation Method

Western blot | Immunohistochemistry

Sample

Livers of WT and Ripk1LPC-KO mice. WB: specimens were lysed in RIPA buffer (50 mM Tris-HCl pH 7.4; 1% Triton X-100; 25 mM HEPES; 150 mM NaCl; 0,2% SDS; 5 mM MgCl2; 1 mM Na3VO4; 1 mM NaF and proteases inhibitors (Roche, #04 693 132 001)). IHC: tissues were fixed in 4% paraformaldehyde and embedded in paraffin. Sections (4–5 μm) were dried 1 h at 58 °C, followed by antigen retrieval.

Blocking agent

WB: non-fat milk or BSA 3–5% in TBS (20 mM Tris, 137 mM NaCl) during 1–2 h.

Primary incubation

WB: overnight at 4 °C.

IHC: in a Ventana automated machine (Ventana Medical Systems, USA).

Secondary incubation

WB: goat anti-rabbit immunoglobulins/HRP (Dako, P0448).

IHC: horseradish peroxidase (HRP)-conjugated secondary antibody (Dako, Glostrup, Denmark).

Detection

WB: enhanced chemiluminescence (Millipore, Billerica, MA, USA) and

ImageQuant LAS-4000 mini imager analysis (GE Healthcare, Chicago, IL, USA).

IHC: DAB substrate kit (Ventana Medical Systems, Tucson, AZ, USA, #760-124).

References
  1. Cuchet Lourenço D, Eletto D, Wu C, Plagnol V, Papapietro O, CURTIS J, et al. Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation. Science. 2018;361:810-813 pubmed publisher
  2. Filliol A, Piquet Pellorce C, Le Seyec J, Farooq M, Genet V, Lucas Clerc C, et al. RIPK1 protects from TNF-α-mediated liver damage during hepatitis. Cell Death Dis. 2016;7:e2462 pubmed publisher
  3. Wang H, Meng H, Li X, Zhu K, Dong K, Mookhtiar A, et al. PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP. Proc Natl Acad Sci U S A. 2017;114:11944-11949 pubmed publisher